KYNTRA BIO, INC.·4

Jun 9, 5:44 PM ET

DeLucia David 4

4 · KYNTRA BIO, INC. · Filed Jun 9, 2026

Research Summary

AI-generated summary of this filing

Updated

KYNTRA BIO (KYNB) CFO David DeLucia — Shares Withheld for Taxes (52)

What Happened

  • David DeLucia, CFO of KYNTRA BIO, had 52 shares withheld by the company to satisfy a tax obligation arising from the vesting of restricted stock units (RSUs). The withholding was executed at $6.71 per share, for a total value of approximately $349. This is a tax-withholding disposition (routine) rather than an open-market sale.

Key Details

  • Transaction date: 2026-06-06
  • Price/share: $6.71; Total value: ~$349
  • Transaction code: F — shares withheld to cover tax liability on RSU vesting
  • Footnote: F1 — issuer withheld shares to satisfy the reporting person's tax obligation upon RSU vesting
  • Filing date: 2026-06-09 (reported on Form 4)
  • Shares owned after transaction: not specified in the information provided

Context

  • This was a tax-withholding event tied to RSU vesting (not an active sale or purchase). Such withholdings are routine and typically do not signal a change in insider conviction.

Insider Transaction Report

Form 4
Period: 2026-06-06
DeLucia David
Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-06-06$6.71/sh52$3494,377 total
Footnotes (1)
  • [F1]Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.
Signature
/s/ John Alden, Attorney-in-Fact|2026-06-09

Documents

1 file
  • 4
    form4-06092026_090631.xmlPrimary